Reports >
Life Sciences
>
Cell Banking Outsourcing Market Report
Cell Banking Outsourcing Market Report
First published: 07 October 2024 | Last updated: 28 May 2026 | Report Code: cell-banking-outsourcing
Cell Banking Outsourcing Market — USD $3.5 Billion in 2023, Growing to USD 6.48B by 2033 at 6.2% CAGR
This report provides an in-depth analysis of the Cell Banking Outsourcing market, including market size forecasts and insights from 2023 to 2033, along with trends, regional breakdowns, and company profiles for key industry players.
Key Takeaways
- Global market grows from $3.50 Billion in 2023 to $6.48 Billion in 2033 at a 6.2% CAGR.
- North America is identified as the largest region, rising from $1.2 Billion in 2023 to $2.22 Billion in 2033.
- North America is largest regional market; Latin America is regional market region based on implied CAGR across 2023 to 2033.
- Europe increases from $0.9 Billion in 2023 to $1.66 Billion in 2033, reflecting expanding demand.
- Top companies operating in the space include Lonza Group, CryoBanking International, Source BioScience, and STEMCELL Technologies.
Cell Banking Outsourcing Market Report — Executive Summary
Regional analysis shows North America as largest market and Latin America as fastest-growing region by implied CAGR. The Cell Banking Outsourcing market is driven by rising demand for cellular therapies, growth in biobanking, and heightened investment in biotechnology. Providers offer storage, preservation, and management services to pharmaceuticals, biotech firms, research institutes, and academic organizations. Technological advancements in storage and handling, along with regulatory adaptation, are shaping service offerings and operations. Regional dynamics vary: North America is the largest market by end-period value, while Latin America is the regional market by implied CAGR. The market structure covers technology, service types, storage formats, expertise areas, and end-user industries. Competitive activity centers on expanding service portfolios, partnerships, and capabilities among established service providers named in the report.
Key Growth Drivers
- Increasing demand for cellular therapies and personalized medicine expands need for outsourced cell storage and handling.
- Advances in biobanking and storage technologies improve long-term viability and service efficiency.
- Rising biotech and pharmaceutical investments fuel demand for contract cell banking services.
- Regulatory evolution and stricter compliance expectations encourage specialized external providers.
- Academic and research institutions increasingly rely on outsourced solutions to access scalable infrastructure.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $3.50 Billion |
| CAGR (2023-2033) | 6.2% |
| 2033 Market Size | $6.48 Billion |
| Top Companies | Lonza Group, CryoBanking International, Source BioScience, STEMCELL Technologies |
| Published Date | 07 October 2024 |
| Last Modified Date | 28 May 2026 |
Cell Banking Outsourcing Market Overview
Customize Cell Banking Outsourcing Market Report market research report
- ✔ Get in-depth analysis of Cell Banking Outsourcing market size, growth, and forecasts.
- ✔ Understand Cell Banking Outsourcing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Cell Banking Outsourcing
What is the Market Size & CAGR of Cell Banking Outsourcing Market Report market in 2023?
Cell Banking Outsourcing Industry Analysis
Cell Banking Outsourcing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Cell Banking Outsourcing Market Report Market Analysis Report by Region
Europe Cell Banking Outsourcing Market Report:
Europe grows from $0.9 Billion in 2023 to $1.66 Billion in 2033. Expansion is fueled by increased adoption of cell therapies, investments in research infrastructure, and adoption of advanced storage and compliance practices.Asia Pacific Cell Banking Outsourcing Market Report:
Asia Pacific grows from $0.73 Billion in 2023 to $1.35 Billion in 2033. Regional gains are supported by growing biotech investment, expanding clinical research, and rising demand for contract storage and management services.North America Cell Banking Outsourcing Market Report:
North America is largest regional market, rising from $1.2 Billion in 2023 to $2.22 Billion in 2033. This scale reflects robust biotech and pharmaceutical activity, broad adoption of outsourced cell storage, and demand for compliant, high-capacity biobanking services.South America Cell Banking Outsourcing Market Report:
Latin America is fastest-growing region by implied CAGR, increasing from $0.29 Billion in 2023 to $0.55 Billion in 2033. Identified as the regional growth market, growth is underpinned by emerging biotech initiatives, rising research activity, and increasing reliance on outsourced cell banking solutions.Middle East & Africa Cell Banking Outsourcing Market Report:
Middle East and Africa grows from $0.38 Billion in 2023 to $0.7 Billion in 2033. Market development is supported by expanding research capacity, investments in healthcare infrastructure, and demand for secure long-term biobanking services.Tell us your focus area and get a customized research report.
Research Methodology
Cell Banking Outsourcing Market Analysis By Service Type
The major service types in the cell banking outsourcing market include automated storage systems and manual storage systems. Automated storage systems accounted for a significant market share in 2023 due to their efficiency and reliability. The market for automated storage systems is projected to grow from $2.86 billion in 2023 to $5.30 billion by 2033, demonstrating strong adoption in biobanking operations. In contrast, manual storage systems represented a smaller segment, with expected growth from $0.64 billion to $1.18 billion, highlighting the gradual shift toward automation.
Cell Banking Outsourcing Market Analysis By Expertise Area
Segmented by expertise area, the market features Hematopoietic Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells. Hematopoietic stem cells dominate the market, projected to rise from $2.37 billion in 2023 to $4.39 billion by 2033. This segment's growth is driven by increasing research and clinical applications in regenerative medicine. Mesenchymal stem cells are similarly significant, extending from $0.89 billion to $1.65 billion, while Induced Pluripotent Stem Cells, though smaller in market size, are gaining traction due to innovations in regenerative therapies.
Cell Banking Outsourcing Market Analysis By End User Industry
The end-user industries for cell banking outsourcing include pharmaceuticals, biotechnology, research institutes, and academic institutions. Pharmaceuticals lead with a size of $1.84 billion in 2023, projected to grow to $3.40 billion by 2033. This reflects the heavy reliance on cell banking for drug development processes. Biotechnology firms follow with growth from $0.83 billion to $1.55 billion, indicating an expanding intersection between biotechnology advancements and cellular therapies.
Cell Banking Outsourcing Market Analysis By Storage Type
Storage types include Liquid Nitrogen Tanks and Vapor Phase Storage. Liquid Nitrogen Tanks dominate with a share of 81.79%, projected to grow from $2.86 billion to $5.30 billion by 2033, while Vapor Phase Storage, with an 18.21% share, is expected to rise from $0.64 billion to $1.18 billion. The efficiency of liquid nitrogen storage in preserving biological materials under ultra-low temperatures fuels its continued preference among operators.
Cell Banking Outsourcing Market Analysis By Technology
In terms of technology, the market reflects ongoing advancements in cellular preservation techniques, including cryopreservation technology and automated storage solutions. Companies are increasingly adopting innovative technological solutions to meet the regulatory requirements of biobanking, as well as enhance operational standards. This sector is projected to witness continuous evolution, ensuring optimized preservation and retrieval of biological samples.
Cell Banking Outsourcing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Cell Banking Outsourcing Industry
Lonza Group:
Lonza is a global leader in bioproducts and contract manufacturing, providing comprehensive services for cell banking and regenerative medicine.CryoBanking International:
A prominent player in the cell banking market, CryoBanking specializes in umbilical cord blood banking, providing critical services for stem cell storage.Source BioScience:
Source BioScience offers a range of bioservices, including cell line banking and biobanking solutions for research and clinical use.STEMCELL Technologies:
STEMCELL Technologies focuses on developing comprehensive tools for cell culture, differentiation, and storage, serving the research and clinical communities.We're grateful to work with incredible clients.
FAQs
What is the market size of the Cell Banking Outsourcing market in 2023?
The market size in 2023 is $3.50 Billion. This figure represents the measured market value at the start of the 2023 to 2033 forecast period.
How big will the market be by 2033?
The market is projected to reach $6.48 Billion in 2033, reflecting growth over the 2023 to 2033 forecast period at the stated CAGR.
What is CAGR for the forecast period?
The reported compound annual growth rate for the 2023 to 2033 period is 6.2%, representing the market's annualized expansion over that decade.
Which region is the fastest Growing in the Cell Banking Outsourcing Market Report market?
Latin America is the fastest-growing region, projected to expand from $0.29 Billion in 2023 to $0.55 Billion in 2033, reflecting an implied 6.61% CAGR over the forecast period.
Which region is the fastest Growing?
Latin America is identified as the regional market region, increasing from $0.29 Billion in 2023 to $0.55 Billion in 2033 at an implied 6.61% CAGR.
Who are the leading companies in the sector?
Top companies listed in the report include Lonza Group, CryoBanking International, Source BioScience, and STEMCELL Technologies, active across service and technology offerings.
What end User industries rely on outsourced cell banking?
Key end users include pharmaceuticals, biotechnology firms, research institutes, and academic institutions, which use outsourced services for storage and sample management.
What are common service types offered by providers?
Reported service types include cell preservation, cell characterization, and cell culturing, reflecting the primary outsourced capabilities used by clients.
How are storage types categorized in the report?
Storage types detailed include Liquid Nitrogen Tank and Vapor Phase Storage, representing the main cryogenic storage formats referenced in the data.
What expertise areas are highlighted?
Expertise areas specified are Hematopoietic Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells, indicating focal cell types serviced by providers.